Also trades as: OBD.L (LSE) · $vol 0M
OXBOF OTC
Oxford BioDynamics Plc
1W: +0.0%
1M: +12.5%
3M: -40.0%
YTD: +28.6%
1Y: -85.1%
3Y: -80.2%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$10M
+25.6% ▲
Capital Expenditures
$244K
+59.0% ▲
5Y CAGR: -11.8%
Free Cash Flow
-$8M
+27.4% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$572K
+83.3% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$8M | -$8M | -$11M | -$12M | -$11M |
| Depreciation & Amort. | $1M | $1M | $1M | $1M | $1M |
| Stock-Based Comp. | $251K | $394K | $332K | $514K | $501K |
| Change in Working Capital | -$213K | $999K | -$671K | -$857K | $1M |
| Other Non-Cash Items | $83K | $184K | $2M | $661K | -$2M |
| Operating Cash Flow | -$6M | -$5M | -$8M | -$10M | -$10M |
| — Investing Activities — | |||||
| Capital Expenditures | -$3M | -$901K | -$250K | -$80K | -$17K |
| Acquisitions (Net) | $0 | -$107K | $0 | $0 | $0 |
| Investment Purchases | $0 | $107K | $0 | $0 | $0 |
| Investment Sales | $3M | $2M | $25K | $0 | $0 |
| Other Investing | $3M | $14K | -$395K | -$1M | $1M |
| Investing Cash Flow | $3M | $1M | -$620K | -$1M | $1M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$690K | -$703K | -$723K | -$622K | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$114K | -$358K | -$1M | -$984K | -$882K |
| Financing Cash Flow | -$804K | $3M | $13M | $8M | $9M |
| Net Change in Cash | -$4M | -$1M | $4M | -$3M | -$572K |
| Cash End of Period | $2M | $974K | $5M | $2M | $2M |
| Free Cash Flow | -$9M | -$6M | -$9M | -$11M | -$8M |